"Omeprazole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Descriptor ID |
D009853
|
| MeSH Number(s) |
D02.886.640.074.500 D03.383.725.024.500 D03.633.100.103.034.500
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Omeprazole".
Below are MeSH descriptors whose meaning is more specific than "Omeprazole".
This graph shows the total number of publications written about "Omeprazole" by people in this website by year, and whether "Omeprazole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 2 | 0 | 2 |
| 2011 | 0 | 1 | 1 |
| 2012 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2016 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Omeprazole" by people in Profiles.
-
Goldstein JL, Scheiman JM, Fort JG, Whellan DJ. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers. J Cardiovasc Pharmacol. 2016 Aug; 68(2):121-6.
-
Goldstein JL, Whellan DJ, Scheiman JM, Cryer BL, Eisen GM, Lanas A, Fort JG. Long-Term Safety of a Coordinated Delivery Tablet of Enteric-Coated Aspirin 325 mg and Immediate-Release Omeprazole 40 mg for Secondary Cardiovascular Disease Prevention in Patients at GI Risk. Cardiovasc Ther. 2016 Apr; 34(2):59-66.
-
Hegarty JP, Sangster W, Harris LR, Stewart DB. Proton pump inhibitors induce changes in colonocyte gene expression that may affect Clostridium difficile infection. Surgery. 2014 Oct; 156(4):972-8.
-
Whellan DJ, Goldstein JL, Cryer BL, Eisen GM, Lanas A, Miller AB, Scheiman JM, Fort JG, Zhang Y, O'Connor C. PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies. Am Heart J. 2014 Oct; 168(4):495-502.e4.
-
Ajmera AV, Shastri GS, Gajera MJ, Judge TA. Suboptimal response to ferrous sulfate in iron-deficient patients taking omeprazole. Am J Ther. 2012 May; 19(3):185-9.
-
Brandt NJ, Stefanacci RG. Discontinuation of unnecessary medications in older adults. Consult Pharm. 2011 Nov; 26(11):845-54.
-
Pratha V, Hogan DL, Lynn RB, Field B, Metz DC. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial. Dig Dis Sci. 2006 Sep; 51(9):1595-601.
-
Pratha VS, Hogan DL, Lane JR, Williams PJ, Burton MS, Lynn RB, Karlstadt RG. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults. Dig Dis Sci. 2006 Jan; 51(1):123-31.
-
Dimarino AJ, Banwait KS, Eschinger E, Greenberg A, Dimarino M, Doghramji K, Cohen S. The effect of gastro-oesophageal reflux and omeprazole on key sleep parameters. Aliment Pharmacol Ther. 2005 08 15; 22(4):325-9.
-
Scheid SC, Anderson TD, Sataloff RT. Nonoperative treatment of laryngeal granuloma. Ear Nose Throat J. 2003 Apr; 82(4):244-5.